Kazia Therapeutics Ltd. funding
Kazia Therapeutics Ltd., a biotechnology company based in Sydney Nsw, Australia, filed a Form D with the SEC on December 18, 2025 and reported $55.3M raised.
Amount raised$55.3M
Offering size$55.3M
Filed with the SECDecember 18, 2025
First saleDecember 3, 2025
IndustryBiotechnology
SecuritiesEquity, Options or warrants, Security to be acquired on exercise
LocationSydney Nsw, Australia
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far65
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Dec 18
Other health care rounds
Lisata Therapeutics, Inc.$352M · Oct 2BiotechnologyPrecision Neuroscience Corp$250M · Sep 28Other Health CareZai Lab Ltd$250M · Nov 9BiotechnologyAmerican Republic Insurance Co.$95M · Oct 22Health InsuranceBridge To Life Ltd.$82.5M · Oct 21Other Health CareAlpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyTypewriter Therapeutics, Inc.$56.3M · Sep 21Biotechnology